Search research articles
Contact Us
Filters
Showing results (161-170 of 232) with videos related to
Page
of 24
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 3, 2016
SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept
Jacob Pr Jacobsen, Meghan L Rudder, Wendy Roberts, et al.
The Journal of Biological Chemistry
|
December 11, 2002
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation
Akira Tohgo, Eric W Choy, Diane Gesty-Palmer, et al.
The Journal of Biological Chemistry
|
March 21, 2007
Inhibition of the dopamine D1 receptor signaling by PSD-95
Jingping Zhang, Angel Vinuela, Mark H Neely, et al.
Experimental Neurology
|
May 16, 2002
Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice
Eric K Richfield, Mona J Thiruchelvam, Deborah A Cory-Slechta, et al.
Frontiers in Systems Neuroscience
|
May 28, 2011
Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum
Emily L Jocoy, Véronique M André, Damian M Cummings, et al.
Journal of Medicinal Chemistry
|
April 30, 2013
Novel adamantyl cannabinoids as CB1 receptor probes
Ganesh A Thakur, Shama Bajaj, Carol Paronis, et al.
Science (New York, N.Y.)
|
September 6, 2003
Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4
Wei Chen, Derk ten Berge, Jeff Brown, et al.
ACS Chemical Neuroscience
|
August 8, 2019
Designing Functionally Selective Noncatechol Dopamine D<sub>1</sub> Receptor Agonists with Potent In Vivo Antiparkinsonian Activity
Michael L Martini, Caroline Ray, Xufen Yu, et al.
ACS Chemical Neuroscience
|
April 8, 2021
Addition to "Designing Functionally Selective Noncatechol Dopamine D<sub>1</sub> Receptor Agonists with Potent In Vivo Antiparkinsonian Activity"
Michael L Martini, Caroline Ray, Xufen Yu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 13, 2006
Dopaminergic control of sleep-wake states
Kafui Dzirasa, Sidarta Ribeiro, Rui Costa, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 232) with videos related to
Sort By:
Page
of 24
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 3, 2016
SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept
Jacob Pr Jacobsen, Meghan L Rudder, Wendy Roberts, et al.
The Journal of Biological Chemistry
|
December 11, 2002
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation
Akira Tohgo, Eric W Choy, Diane Gesty-Palmer, et al.
The Journal of Biological Chemistry
|
March 21, 2007
Inhibition of the dopamine D1 receptor signaling by PSD-95
Jingping Zhang, Angel Vinuela, Mark H Neely, et al.
Experimental Neurology
|
May 16, 2002
Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice
Eric K Richfield, Mona J Thiruchelvam, Deborah A Cory-Slechta, et al.
Frontiers in Systems Neuroscience
|
May 28, 2011
Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum
Emily L Jocoy, Véronique M André, Damian M Cummings, et al.
Journal of Medicinal Chemistry
|
April 30, 2013
Novel adamantyl cannabinoids as CB1 receptor probes
Ganesh A Thakur, Shama Bajaj, Carol Paronis, et al.
Science (New York, N.Y.)
|
September 6, 2003
Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4
Wei Chen, Derk ten Berge, Jeff Brown, et al.
ACS Chemical Neuroscience
|
August 8, 2019
Designing Functionally Selective Noncatechol Dopamine D<sub>1</sub> Receptor Agonists with Potent In Vivo Antiparkinsonian Activity
Michael L Martini, Caroline Ray, Xufen Yu, et al.
ACS Chemical Neuroscience
|
April 8, 2021
Addition to "Designing Functionally Selective Noncatechol Dopamine D<sub>1</sub> Receptor Agonists with Potent In Vivo Antiparkinsonian Activity"
Michael L Martini, Caroline Ray, Xufen Yu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 13, 2006
Dopaminergic control of sleep-wake states
Kafui Dzirasa, Sidarta Ribeiro, Rui Costa, et al.
Page
of 24